Subscribe Now
 Already a subscriber? Log-in!
The monthly Laboratory Industry Report delivers expert perspective and trusted guidance on critical regulatory updates, operational and financial trends, plus trusted forecasts on the future of the diagnostic laboratory industry.
As a member of the Laboratory Industry Report community, you’ll take advantage of over 30 years of experience including:
- Expert strategies and advice on healthcare integration, capitation, lab technology and more
- Analysis of regulatory impact and relevant details on proposed legislation
- Comparative data on diagnostic lab test pricing and volumes
- Benchmarks to gauge your lab operations versus the diagnostic lab market at large
- Details on publicly-held labs, including executive earnings and performance
- Updates on industry mergers, acquisitions and alliances and large labs’ business activities
Laboratory Industry Report gives you direct access to industry experts to keep you current and informed on the latest issues affecting diagnostic laboratories across practice settings – hospital, commercial, group practice sites and network systems.
Clients find their membership to “LIR” to be much more than a news source; it’s where they to turn for business intelligence and exclusive insight on what's happening to key companies, how Wall Street views the industry, or the latest on mergers, buyouts, consolidations and alliances.
For over 30 years Laboratory Industry Report is a trusted resource for everyone with a vital stake in today's competitive diagnostic lab marketplace – from owners, directors, pathologists, CEOs, COOs, and CFOs to general managers, administrators, lab managers, and sales/marketing professionals.
As always Laboratory Industry Report, guarantees the accuracy, objectivity, and authority of its actionable
intelligence.
Gain a competitive edge for your diagnostic lab!
|
|
|
 |
 | LIR March 2010 (Full PDF Issue) |
| TOP OF THE NEWS
Physician fee cut freeze set to end on March 1
Carilion-Spectrum merger shakes up industry
EARNINGS UPDATE
LabCorp’s Q409 revenues up 3.4%
CancerGuide Dx signs deal with LabCorp
INSIDE THE LAB INDUSTRY
Nine legal rules for lab sales and marketing
NEWSMAKERS
Bostwick closes AIPL after six months
BENCHMARKING
Myriad Genetics leads in preliminary FY09 analysis
INDUSTRY NEWS
Baylor Health Care-US Oncology in joint venture
Oral arguments heard in gene patents case
FINANCIAL
Lab index down 10% over last five weeks
INDUSTRY BUZZ
MedPAC confronts lab tests and in-office ancillary services exception
Full Article |
| Carilion-Spectrum Merger to Shake Up Lab Industry’s Duopolistic Stronghold in Mid-Atlantic and Southern Regions |
| The recent merger of Roanoke, Va.-based Carilion Labs and Greensboro, N.C.-based Spectrum Laboratory Network is set to disrupt the current competitive environment in the Mid-Atlantic and Southern regions, as well as intensify the already compressed pricing environment, say industry insiders.
Full Article |
| Time Ticking as Physician Fee Cut Freeze Expires on March 1; Congress’s Next Move Remains Unclear |
| As the freeze on the update to Medicare physician payments is set to end on March 1, it’s unclear at press time how Congress will address the issue when it reconvenes the week of Feb. 22 after a week-long recess. Medicare reimbursement to doctors is scheduled to be reduced 21 percent under the Sustainable Growth Rate (SGR) formula on March 1.
Full Article |
| LabCorp’s Q409 Revenues Up 3.4% to $1.16 Billion; Economy Still Challenges Volume Growth in 2010 |
|
The nation’s second largest testing provider ended 2009 in strong fashion, with fourth-quarter revenues up 3.4 percent to $1.16 billion, and full-year revenues climbing 4 percent to $4.69 billion. This is solid growth for LabCorp (Burlington, N.C.), particularly compared to fourth-quarter and full-year results from the industry leader, Quest Diagnostics (Madison, N.J.)—which reported fourth-quarter revenue growth of 2.7 percent to $1.8 billion and full-year revenue growth of 2.8 percent to $7.5 billion. …
Full Article |
| Inside the Lab Industry: Managing Risk in Lab Sales and Marketing: Nine Rules to Sell By |
| Health care providers, including laboratories and pathologists, face restrictions on their sales and marketing practices that many other professionals do not have to contend with. Violation of key laws can result in substantial financial penalties, warns Hope Foster, an attorney with Mintz Levin (Washington, D.C.).
Full Article |
| Bostwick Shutters AIPL after Only Six Months; Announces Tenn. Closure |
| Citing economic pressures, anatomic pathology (AP) testing provider Bostwick Laboratories (Richmond, Va.) has shut down its Washington, D.C., metro-based American International Pathology Laboratories (AIPL) only six months after its launch, according to a company memo from CEO and chief medical officer David Bostwick, M.D., recently obtained by LIR.
Full Article |
| Myriad Genetics Emerges as Early Leader in G-2’s Preliminary FY09 Benchmarking Analysis |
| While not all the publicly traded labs’ full-year 2009 results are in and 10-Ks have been filed, some early analysis of productivity data reveals that Salt Lake City specialty testing provider Myriad Genetics is showing big gains in two benchmarking measures: revenue per full-time employee (FTE) and pretax income per employee (see Table).
Full Article |
| Oral Arguments Heard in Gene Patents Lawsuit |
| Both sides in the landmark lawsuit challenging the patenting of human genes have asked a federal court to rule in their favor without a trial during oral arguments at a Feb. 2 hearing in New York City, reports Washington G-2 Reports’ National Intelligence Report. This marks the first time that a challenge to gene patenting has been heard in federal court.
Full Article |
| Baylor Health Care Launches Joint Venture with US Oncology |
| Dallas-based Baylor Health Care will team up with Houston-based cancer care and research company US Oncology to launch a molecular diagnostic laboratory.
Full Article |
| Lab Index Continues Winter Slump; Down 10% Over Last Five Weeks |
| The 13 publicly traded labs tracked by G-2 Reports’ Laboratory Stock Index continue to struggle in early 2010.
Full Article |
| Industry Buzz: MedPAC Considers Removing Some Lab Tests from In-Office Ancillary Services Exception |
| The Medicare Payment Advisory Commission (MedPAC) is considering three options for addressing problems resulting from in the in-office ancillary services exception to the Stark law, including excluding certain services from the exception (such as diagnostic tests that are not usually provided at the same time as the office visit).
Full Article |
|
|
Please choose an archived issue to view newsletter table of contents above
|
|
